Iovance Biotherapeutics, Inc.
IOVA NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 6, 2026
ET
EPS Est.
-0.13
EPS Actual
-0.11
Revenue Est.
$87.8M
Revenue Actual
$99.3M
Next Earnings Report Date unconfirmed
Date
Nov 5, 2026 · Thu
Time
Time TBD
Fiscal Period
--
EPS Est.
-0.09
Revenue Est.
$114.1M
Company Overview
Iovance Biotherapeutics, Inc. (ticker IOVA) is listed on NASDAQ with a market cap of about $6.35B. Its next earnings report is expected on Nov 5, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of -0.09. In the last 15 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Feb 28, 2023 → Aug 6, 2026
Feb 28, 2023Range: -0.64 ~ -0.11Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -0.13 | Above forecast↑-0.11 | $87.8M | $99.3M |
| May 7, 2026 | -- | -0.19 | -0.19 | $77.8M | $71.4M |
| Feb 24, 2026 | -- | -0.22 | Above forecast↑-0.18 | $80.7M | $86.7M |
| Nov 6, 2025 | -- | -0.29 | Above forecast↑-0.25 | $82.2M | $67.5M |
| Aug 7, 2025 | -- | -0.29 | Below forecast↓-0.33 | $78.3M | $60M |
| May 8, 2025 | -- | -0.25 | Below forecast↓-0.36 | $82.4M | $49.3M |
| Feb 27, 2025 | -- | -0.26 | -0.26 | $72.2M | $73.7M |
| Nov 7, 2024 | -- | -0.31 | Above forecast↑-0.28 | $71.6M | $58.6M |
| Aug 8, 2024 | -- | -0.37 | Above forecast↑-0.34 | $24.6M | $31.1M |
| May 9, 2024 | -- | -0.45 | Above forecast↑-0.42 | $2.1M | $715000 |
| Feb 28, 2024 | -- | -0.44 | Below forecast↓-0.45 | $1.4M | $482000 |
| Nov 7, 2023 | -- | -0.46 | -0.46 | $1.7M | $469000 |
| Aug 8, 2023 | -- | -0.81 | Above forecast↑-0.47 | $3.6M | $238000 |
| May 9, 2023 | -- | -0.84 | Above forecast↑-0.50 | $200000 | -- |
| Feb 28, 2023 | -- | -0.64 | -0.64 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-08-06 ↗
Earnings Release8-K · 2026-08-06 ↗
Earnings Release8-K · 2026-05-07 ↗
Quarterly10-Q · 2026-05-07 ↗
Annual10-K · 2026-02-24 ↗
Earnings Release8-K · 2026-02-24 ↗
Quarterly10-Q · 2025-11-06 ↗
Earnings Release8-K · 2025-11-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
